Mylan announces nationwide EpiPen recall over potential defect

Mylan announces nationwide EpiPen recall over potential defect

Mylan announces nationwide EpiPen recall over potential defect

The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the company's allergy treatment failing to work in emergencies. That related to two devices - from one lot - failing to activate.

Mylan called the defect "extremely rare", and is recalling 13 lots of the pens.

The recall affects 13 lots of EpiPen and EpiPen Jr. devices distributed between December 17, 2015, and July 1, 2016. (0.15 mg) are sold as 2 Pak Auto-Injectors.

Mylan said it's extending the lots included in the recall as a precautionary measure.

Trump to Lawmakers: Deal on PPACA Overhaul Expected "Very Quickly"
The episode has left Republicans divided into camps that are happy to blame each other for the legislation's failure. The chairman of the House tax committee declared Monday he is "turning the page" from health care to tax reform....

Census Still Won't Include LGBT Questions
Questions about sexual orientation and gender identity have never appeared in the census or American Community Survey. Census Bureau has backed away from plans to collect data about Americans' sexual orientation and gender identity.

John Legend Surprises London Commuters with an Impromptu Performance
The performance was uploaded as a live stream to promoter Live Nation's Facebook page where it was viewed by 42,000 users. The singer is promoting his forthcoming world tour, which is due to reach the United Kingdom in September.

EpiPen Jr (0.15 mg epinephrine) auto-injector lot 5GR765, expiry date March 2017. Patients, customers and distributors are being notified and should refer to Mylan.com/EpiPenRecall for updates on product return and replacement instructions.

In response, Mylan started offering $300 savings cards for patients who have to pay full price and began developing its generic spinoff.

Replacement EpiPens can be obtained from your pharmacy, if it has the auto-injector (or its generic equivalent) in stock.

Adverse reactions or quality problems experienced with the use of this product may be reported to 1-866-723-7111 or by fax at 1-855-242-5652. Delays in epinephrine administration have been associated with negative health consequences.

Related news